Newsroom | 4566 results

YOKOHAMA, Japan--(BUSINESS WIRE)--Der Weltkongress für Nephrologie 2026 (WCN'26), die wichtigste Veranstaltung der Internationalen Gesellschaft für Nephrologie (ISN), findet vom 28. bis 31. März 2026 in Yokohama statt. Der Kongress wird gemeinsam von der Japanischen Gesellschaft für Nephrologie (JSN) und der Asiatisch-Pazifischen Gesellschaft für Nephrologie (APSN) ausgerichtet. Das Yokohama City Visitors Bureau (YCVB) und PACIFICO Yokohama unterstützten in Zusammenarbeit mit der Stadt Yokohama...

YOKOHAMA, Japon--(BUSINESS WIRE)--Le Congrès mondial de néphrologie 2026 (WCN’26), événement phare de la Société internationale de néphrologie (ISN), se tiendra à Yokohama du 28 au 31 mars 2026. Le Congrès est co-organisé par la Société japonaise de néphrologie (JSN) et la Société de néphrologie de l'Asie-Pacifique (APSN). L'Office du tourisme de la ville de Yokohama (YCVB) et PACIFICO Yokohama, en collaboration avec la municipalité de Yokohama, ont soutenu la candidature dirigée par le profess...

YOKOHAMA, Japan--(BUSINESS WIRE)--Het Wereldcongres voor Nefrologie 2026 (WCN’26), het vooraanstaande evenement van de International Society of Nephrology (ISN), zal plaatsvinden in Yokohama van 28 maart tot 31 maart 2026. Het congres zal mede worden georganiseerd door de Japanese Society of Nephrology (JSN) en de Asian Pacific Society of Nephrology (APSN). Het Yokohama City Visitors Bureau (YCVB) en PACIFICO Yokohama, in samenwerking met de stad Yokohama, ondersteunde het bod dat werd geleid d...

YOKOHAMA, Giappone--(BUSINESS WIRE)--Il World Congress of Nephrology 2026 (WCN’26), prestigioso evento della International Society of Nephrology (ISN), si svolgerà a Yokohama dal 28 al 31 marzo 2026. A ospitare congiuntamente il Congresso saranno la Japanese Society of Nephrology (JSN) e la Asian Pacific Society of Nephrology (APSN). La candidatura della città nipponica a sede del congresso, guidata dal Prof. Masaomi Nangaku, Presidente della Japanese Society of Nephrology è stata sostenuta dal...

YOKOHAMA, Japón--(BUSINESS WIRE)--El Congreso Mundial de Nefrología 2026 (WCN'26), el evento principal de la Sociedad Internacional de Nefrología (ISN), se celebrará en Yokohama del 28 al 31 de marzo de 2026. El Congreso será organizado en conjunto por la Sociedad Japonesa de Nefrología (JSN) y la Sociedad de Nefrología del Pacífico Asiático (APSN). La oficina de turismo de la ciudad de Yokohama (YCVB) y PACIFICO Yokohama, en colaboración con la ciudad de Yokohama, apoyaron la candidatura encab...

YOKOHAMA, Japan--(BUSINESS WIRE)--World Congress of Nephrology to be Held in Yokohama—City to Host Global Kidney Experts at WCN’26....

SAN DIEGO--(BUSINESS WIRE)--Dexcom Appoints Jon Coleman as Chief Commercial Officer...

BOSTON--(BUSINESS WIRE)--Porosome Therapeutics, Inc. (Porosome Therapeutics) today announced its latest development in identifying the secretory dysfunction responsible for Alzheimer’s Disease along with advancements in therapeutic neuronal nanomachines. These innovations may transform the future of Alzheimer’s research and treatment approaches. The company’s new findings suggest that combining porosome restoration with small molecule and peptide therapy may not only slow the progression of Alz...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc announces that it has been named a winner of the 2025 BIG Artificial Intelligence Excellence Award....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for apitegromab, an investigational muscle-targeted treatment that is being developed to provide clinically meaningful improvement in motor function for...